🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized phase III trial studies how well imatinib mesylate works in...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-08-08
Trial ID
NCT03007147
Treatments Being Tested
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
Lupus nephritis (LN) develops in 30-60% of systemic lupus erythematosus (SL...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-01
Trial ID
NCT07505576
This multi-center, open-label, phase II randomized controlled trial is to e...
Status
Suspended
Location
Sun Yat-sen Memorial Hospital
Start Date
2016-09
Trial ID
NCT02897050
This phase Ib/II trial studies the side effects of IRX-2, cyclophosphamide,...
Status
Completed
Location
HonorHealth Research Institute
Start Date
2019-04-19
Trial ID
NCT03918499
Treatments Being Tested
This phase II trial studies how well a dose adjusted regimen consisting of ...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2015-01-14
Trial ID
NCT02199184
Severe aplastic anemia is a fatal disease and patients without HLA matched ...
Status
Unknown
Location
Seoul National University Hospital
Start Date
2008-11
Trial ID
NCT00881933
Treatments Being Tested
Single agent, non-randomized, open label expansion in select sarcoma patien...
Status
Unknown
Location
Children's Hospital Los Angeles
Start Date
2018-06-04
Trial ID
NCT03600649
Treatments Being Tested
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615
Current treatments for relapsed/refractory hematopoietic malignancies such ...
Status
Unknown
Location
Multiple Locations
Start Date
2021-03
Trial ID
NCT04767308
Treatments Being Tested